MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer

作者: Xiaoping Liu , Hailin Tang , Jianping Chen , Cailu Song , Lu Yang

DOI: 10.18632/ONCOTARGET.4039

关键词:

摘要: Triple-negative breast cancer is the most aggressive subtype. The aim of our study was to investigate functional role both miR-101 and MCL-1 in sensitivity human triple-negative (TNBC) paclitaxel. We found that expression strongly decreased tissues cell lines. not associated with clinical stage or lymph node infiltration TNBC. Ectopic overexpression inhibit growth induced apoptosis vitro suppressed tumorigenicity vivo. significantly overexpressed TNBC Luciferase assay results confirmed as a direct target gene miR-101. MiR-101 inhibited cells transplanted tumors. There negative correlation between level tissues. Suppression enhanced MDA-MB-435 Furthermore, increased paclitaxel by inhibiting expression. Our findings provide significant insight into molecular mechanisms carcinogenesis may have relevance for development novel, targeted therapies

参考文章(33)
Yosuke Konno, Peixin Dong, Ying Xiong, Fumihiko Suzuki, Jiabin Lu, Muyan Cai, Hidemichi Watari, Takashi Mitamura, Masayoshi Hosaka, Sharon J. B. Hanley, Masataka Kudo, Noriaki Sakuragi, MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells Oncotarget. ,vol. 5, pp. 6049- 6062 ,(2014) , 10.18632/ONCOTARGET.2157
Yongjun Wang, Wei Xiang, Miao Wang, Tao Huang, Xingyuan Xiao, Liang Wang, Dan Tao, Liyun Dong, Fuqing Zeng, Guosong Jiang, Methyl jasmonate sensitizes human bladder cancer cells to gambogic acid-induced apoptosis through down-regulation of EZH2 expression by miR-101. British Journal of Pharmacology. ,vol. 171, pp. 618- 635 ,(2014) , 10.1111/BPH.12501
Girish C. Shukla, Sailen Barik, Jagjit Singh, MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions. Molecular and Cellular Pharmacology. ,vol. 3, pp. 83- 92 ,(2011) , 10.4255/MCPHARMACOL.11.13
Elvira D'Ippolito, Marilena Iorio, MicroRNAs and triple negative breast cancer. International Journal of Molecular Sciences. ,vol. 14, pp. 22202- 22220 ,(2013) , 10.3390/IJMS141122202
Yu-mei Rao, Hui-rong Shi, Mei Ji, Cai-hong Chen, None, MiR-106a targets Mcl-1 to suppress cisplatin resistance of ovarian cancer A2780 cells Journal of Huazhong University of Science and Technology [Medical Sciences]. ,vol. 33, pp. 567- 572 ,(2013) , 10.1007/S11596-013-1160-5
Angela R. Bradbury, Olufunmilayo I. Olopade, Genetic susceptibility to breast cancer Reviews in Endocrine & Metabolic Disorders. ,vol. 8, pp. 255- 267 ,(2007) , 10.1007/S11154-007-9038-0
Richard J. Youle, Andreas Strasser, The BCL-2 protein family: opposing activities that mediate cell death Nature Reviews Molecular Cell Biology. ,vol. 9, pp. 47- 59 ,(2008) , 10.1038/NRM2308
FEI LU, JINGRU ZHANG, MIN JI, PENG LI, YAHUI DU, HONGCHUN WANG, SHAOLEI ZANG, DAOXIN MA, XIULIAN SUN, CHUNYAN JI, miR‑181b increases drug sensitivity in acute myeloid leukemia via targeting HMGB1 and Mcl-1 International Journal of Oncology. ,vol. 45, pp. 383- 392 ,(2014) , 10.3892/IJO.2014.2390
Jie Gao, Laisheng Li, Minqing Wu, Min Liu, Xinhua Xie, Jiaoli Guo, Hailin Tang, Xiaoming Xie, MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1 PLoS ONE. ,vol. 8, pp. e65138- ,(2013) , 10.1371/JOURNAL.PONE.0065138
Hang Su, Jian-Rong Yang, Teng Xu, Jun Huang, Li Xu, Yunfei Yuan, Shi-Mei Zhuang, MicroRNA-101, Down-regulated in Hepatocellular Carcinoma, Promotes Apoptosis and Suppresses Tumorigenicity Cancer Research. ,vol. 69, pp. 1135- 1142 ,(2009) , 10.1158/0008-5472.CAN-08-2886